Title: Study of Prevalence of Diabetic Retinopathy in Already Confirmed Diabetic Patients Who Were Reffered for Screening Purpose

Authors: Parvez Ahmad Bhat, Jasia Ishtiaq, Arsalan un Nisa, Wallied K Ballwan, Wani Prince Muzaffar

 DOI:  http://dx.doi.org/10.18535/jmscr/v3i8.05

DIDS : 08.2015-42257825

Abstract

Objective: To study prevalence of diabetic retinopathy among diabetic patients referred for screening purpose.

Methods: Total of 2716 diabetic patients who were referred to our ophthalmology department for screening were included in the study. Complete eye examination including visual acuity, anterior segment examination and dilated fundus exam was performed. Age specific prevalence of diabetic retinopathy was recorded and also duration of diabetes was considered. Diabetic retinopathy if present was graded according to ETDRS grading system.

Results: Out of 2716 patients in 2273 (84%) revealed no diabetic retinopathy and in 443 (16%) revealed varying degree of diabetic retinopathy. Most of the diabetic retinopathy patients were aged between 60-90 years and least number were between 37-60 years age group. Duration of diabetes was the single most important risk factor for diabetic retinopathy. 56% of diabetic retinopathy patients had duration of diabetes of more than 10 years, where 12% had 5-10 years duration and only 3% had duration of diabetes of less than 5 years. Mild NPDR was the most common type of diabetic retinopathy (52%) followed by severe NPDR (22%), moderate NPDR (17%), NPDR with CSME (6%) and PDR (3%).

Conclusion: Diabetic retinopathy is a visually blinding complication of diabetes. Two most important ways to prevent it is to exercise a strict glycemic control and to do a regular dilated fundus examination to detect it at an early stage.

Keywords: NPDR (non-proliferative diabetic retinopathy), PDR (proliferative diabetic retinopathy), CSME (clinically significant macular edema), ETDRS (Early treatment diabetic retinopathy study).

References

1.      Klein R, Klein BE, Moss SE. visual impairment in diabetics. Ophthalmology 1984; 91: 1-9.

2.      DwyerMS, Melton J, Ballard DJ, et al. Incidence of diabetic retinopathy and blindness, A population based study. Diabetes Care 1985; 8: 316-322.

3.      The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in United States. Arch Ophthalmol 2004; 122: 552-563.

4.      Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimated for the year 2000 and projection for 2030. Diabetes Care 2004; 27: 1047-1053.

5.      Mohan V, Ramachandran A, Snehalatha C. High prevalence of maturity onset diabetes of young among Indians. Diabetes Care 1985; 8: 371-374.

6.      Mohan V, Shanthirani CS, Deepa R. Glucose intolerance in a selected southern Indian population with  special reference to family history, and life style. J Assoc physician India 2003; 51: 771-777.

7.      King H, Aubert RE, Herman WH. Global burden of diabetes (1995-2025). Diabetes Care 1998; 21: 1414-31.

8.      Aiello LM, Rand LI, Brones JC. Diabetic retinopathy in Joslin Clinic in patients with adult onset diabetes. Ophthalmology 1981; 88: 619-23.

9.      Ruiz RS, Saatci OA. PCIOL implantation in eyes with active diabetic retinopathy. Am J Ophthalmol 1991; 111: 158-62.

Corresponding Author

Dr. Parvez Ahmad Bhat

Senior Resident, Department of Ophthalmology, SKIMS Srinagar (J&K) India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Cell: +91-9906483578